Fabros, Loreta .
HRN: 23-01-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/04/2023
06/11/2023
IV
1.5
Q8
Aspiration Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes